Oncology Institute (NASDAQ:TOI – Get Free Report) is set to post its quarterly earnings results after the market closes on Tuesday, May 14th. Analysts expect Oncology Institute to post earnings of ($0.12) per share for the quarter. Oncology Institute has set its FY 2024 guidance at EPS.Parties that are interested in registering for the company’s conference call can do so using this link.
Oncology Institute (NASDAQ:TOI – Get Free Report) last posted its quarterly earnings results on Wednesday, March 27th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.10). Oncology Institute had a negative net margin of 24.56% and a negative return on equity of 80.46%. The business had revenue of $85.79 million for the quarter, compared to analysts’ expectations of $82.04 million. On average, analysts expect Oncology Institute to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Oncology Institute Trading Down 12.1 %
NASDAQ TOI opened at $0.94 on Tuesday. The company has a current ratio of 4.12, a quick ratio of 3.73 and a debt-to-equity ratio of 1.52. The stock has a 50-day moving average of $1.48 and a 200-day moving average of $1.75. The firm has a market cap of $69.91 million, a PE ratio of -1.02 and a beta of 0.82. Oncology Institute has a 1-year low of $0.33 and a 1-year high of $2.66.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on TOI
About Oncology Institute
The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.
Featured Articles
- Five stocks we like better than Oncology Institute
- What Are Dividend Champions? How to Invest in the Champions
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- How to Use the MarketBeat Stock Screener
- 3 Value Stocks You Can Buy Before They Become Big
- How to Invest in Small Cap Stocks
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.